RGNX vs MSFT: Which Stock is Better?
Side-by-side comparison of Regenxbio Inc and Microsoft Corporation in 2026
RGNX
Regenxbio Inc
$9.32
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | RGNX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $440.40M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | RGNX |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 22.9% | 18.4% | RGNX |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze RGNX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is RGNX or MSFT a better investment?
Comparing RGNX and MSFT: Regenxbio Inc has a market cap of $440.40M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between RGNX and MSFT?
RGNX (Regenxbio Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: RGNX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: RGNX or MSFT?
RGNX has higher revenue growth at 22.9% vs 18.4% for MSFT.
Which company is more profitable: RGNX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for RGNX.
Which is the larger company: RGNX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $440.40M for RGNX.
Should I buy RGNX or MSFT in 2026?
Both RGNX and MSFT have investment merit. RGNX trades at $9.32 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between RGNX and MSFT stock?
Key differences: Market Cap ($440.40M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (22.9% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy RGNX or MSFT in 2026?
The choice between RGNX and MSFT depends on your investment goals. RGNX shows higher revenue growth (22.9%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between RGNX and MSFT?
RGNX (Regenxbio Inc) has a market cap of $440.40M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.